Dexmedetomidine Versus Propofol in the Medical Intensive Care Unit (MICU)
Mechanical Ventilation, Critical Illness
About this trial
This is an interventional treatment trial for Mechanical Ventilation focused on measuring Hypnotics and Sedatives, Respiration, Artificial, Ventilators, Mechanical, Critical care, Intensive care, Physical therapy, Occupational therapy, Sedative medications
Eligibility Criteria
Inclusion Criteria:
- >18 years old
- mechanically ventilated through endotracheal tube
- anticipated need for ventilation > 48 hours
- requiring sedative/analgesic medication
Exclusion Criteria:
- on mechanical ventilator > 96 hours
- primary neurologic disease
- post cardiac arrest
- do not speak English (assessment only English language validated)
- pregnancy or lactation
- active myocardial ischemia
- second or third degree heart block
- pancreatitis
- elevated serum triglycerides (> 400 mg/dL)
Sites / Locations
- The University of Chicago Medical Center
Arms of the Study
Arm 1
Arm 2
Active Comparator
Active Comparator
Dexmedetomidine
Propofol
Patients in this arm will receive continuous dexmedetomidine infusion (0.2 - 1.5 mcg/kg/hour) titrated to the target Richmond Agitation Sedation Scale for the duration of mechanical ventilation or 7 days on study, whichever is first.
Patients in this arm will receive propofol (5 - 50 mcg/kg/min) for sedation, titrated to the target Richmond Agitation Sedation Scale for the duration of mechanical ventilation or 7 days on study, whichever is first.